Drug intelligence / Profile preview

fuzheng quxie prescription + yifei sanjie prescription

Development stage
Unknown
Lead developer
Shanghai Municipal Hospital of Traditional Chinese Medicine
Administration
Oral
01

Overview

Fuzheng Quxie prescription + Yifei Sanjie prescription is a combined traditional Chinese medicine (TCM) formulation developed by the Shanghai Municipal Hospital of Traditional Chinese Medicine. It is being investigated for the treatment of cancer-related fatigue (CRF) in patients with non-small cell lung cancer (NSCLC) undergoing postoperative adjuvant chemotherapy. The Yifei Sanjie component, also known as Yiqi Chutan Tang, is a classical TCM formula composed of multiple herbal ingredients including Panax quinquefolius Radix (Xi yang shen), Ranunculi Ternati Radix (Mao zhao cao), Sarcandrae Herba (Zhong jie feng), Pinelliae Rhizoma Praeparatum (Fa ban xia), Ganoderma (Ling zhi), Bombyx batryticatus (Chao jiang can), Cremastrae Pseudobulbus Pleiones Pseudobulbus (Shan ci gu), and Fritillariae Thunbergii Bulbus (Zhe bei mu). The proposed mechanism of action involves reducing skeletal muscle injury, inhibiting mitophagy and mitochondrial damage, and reducing oxidative stress.

Other names
Fuzheng Quxie RecipeYifei Sanjie prescriptionYiqi Chutan TangYiqi Chutan prescription

Beyond the preview

Go deeper on fuzheng quxie prescription + yifei sanjie prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fuzheng quxie prescription + yifei sanjie prescription.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call